ClinicalTrials.Veeva

Menu

Green Propolis Extract and Royal Jelly in Hypertensive Patients and/or With Chronic Kidney Disease

U

Universidade Federal Fluminense

Status

Enrolling

Conditions

Hypertension
Chronic Kidney Diseases
Cardiovascular Diseases

Treatments

Dietary Supplement: Placebo
Dietary Supplement: Propolis associated with Royal Jelly
Dietary Supplement: Royal Jelly

Study type

Interventional

Funder types

Other

Identifiers

NCT06288204
Denise Mafra16

Details and patient eligibility

About

This work aims to evaluate the effects of the association of green propolis extract with royal jelly on inflammation and oxidative stress in participants with chronic kidney diseases (CKD) and Systemic arterial hypertension (SAH), in a longitudinal, randomized, double-blind, placebo-controlled clinical trial that will be carried out for 2 months.

Full description

Propolis and royal jelly are bee products. Propolis is a resinous mixture produced by bees with their saliva and the addition of wax, from exudates collected from buds and plant sap. Royal jelly is a substance produced in the hypopharyngeal glands of young worker bees. Both products are rich in bioactive compounds such as polyphenols. The combination of propolis extract and royal jelly, substances constituted by the combination of several chemical components with potential biological activity, may emerge as a promising adjuvant therapeutic alternative for patients with CKD and SAH.

Enrollment

153 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients in stages 3 and 5 of CKD (GFR from 15 to 59 mL/min),
  • patients receiving ambulatorial nutrition treatment at least 6 months
  • patients on regular Hemodialysis treatment for at least 6 months
  • patients using one to three antihypertensive drugs

Exclusion criteria

  • autoimmune and infectious diseases,
  • diabetes
  • cancer
  • AIDS
  • pregnant women
  • patients using catabolic drugs or antibiotics;
  • patients with catheter access to hemodialysis;
  • patients using antioxidant vitamin supplements, prebiotics, probiotics, symbiotic,
  • Patients on regular intake of propolis who are allergic to corn starch or report being allergic to bee stings.
  • patients with acute myocardial infarction (AMI) and/or cerebrovascular accident (CVA)

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

153 participants in 3 patient groups, including a placebo group

Propolis associated with Royal Jelly Group
Experimental group
Description:
4 capsules a day, providing daily royal jelly in an amount of 100 mg/day plus 500 mg/day of propolis together, for 2 months.
Treatment:
Dietary Supplement: Propolis associated with Royal Jelly
Royal Jelly
Experimental group
Description:
Royal Jelly will receive 1 capsule a day, providing daily royal jelly in an amount of 100 mg/day, for 2 months.
Treatment:
Dietary Supplement: Royal Jelly
Placebo
Placebo Comparator group
Description:
4 capsules a day of placebo.
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

2

Loading...

Central trial contact

Denise Mafra, PhD; Ludmila Cardozo, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems